2023
DOI: 10.1016/s2352-3018(23)00008-5
|View full text |Cite
|
Sign up to set email alerts
|

HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 26 publications
1
7
0
Order By: Relevance
“…The present study findings support prior work among cisgender sexual minority participants and research on mental health and HIV diagnosis among transgender people. However, there are limited data comparing the prevalence of cardiovascular disease, kidney disease, diabetes, and hypertension among transgender and gender diverse participants with cisgender populations.…”
Section: Discussionsupporting
confidence: 86%
“…The present study findings support prior work among cisgender sexual minority participants and research on mental health and HIV diagnosis among transgender people. However, there are limited data comparing the prevalence of cardiovascular disease, kidney disease, diabetes, and hypertension among transgender and gender diverse participants with cisgender populations.…”
Section: Discussionsupporting
confidence: 86%
“…In a large 2023 USA study focusing on indices of HIV risk among transgender women, unexpectedly high mortality was found. Although none of these deaths were HIV-related, the authors suggested that the issue is indicative of poor care and should not be neglected [ 97 ]. In terms of essential Pre-Exposure Prophylaxis (PrEP) medication for HIV prevention, another recent scoping review found high willingness (80%) to use PrEP among transgender women worldwide, yet low uptake and adherence (35.4%), with socioeconomic determinants, including poverty, substance use, stigma, and mistrust, again driving this phenomenon [ 98 ], in line with the barriers identified by this study.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, people who identify as transgender have higher rates of HIV (CDC, 2021b) and accessing gender-affirming care may serve as a route of engagement in preventive and HIV care (Van Gerwen & Blumenthal, 2023). Transwomen with access to gender affirming care are less likely to acquire HIV and are much less likely to die (Wirtz et al, 2023). Many programs and clinicians may offer to meet someone's gender affirming transition-related care priorities first and then integrate HIV prevention or treatment as they are ready (Van Gerwen & Blumenthal, 2023).…”
Section: Policies Influencing Public Health and Health Carementioning
confidence: 99%